1. Kang SJ, Tae CH, Bang CS, et al. International Digestive Endoscopy Network consensus on the management of antithrombotic agents in patients undergoing gastrointestinal endoscopy. Clin Endosc. 2024; 57:141–157. DOI:
10.5946/ce.2024.002. PMID:
38556472.
2. Scaramella L, Zammit SC, Sidhu R, et al. Effect of antithrombotic therapies on small bowel bleeding: an European multicenter retrospective study. Clin Endosc. 2025; 58:102–111. DOI:
10.5946/ce.2024.073. PMID:
39623861.
3. Kim SE, Kim HJ, Koh M, et al. A practical approach for small bowel bleeding. Clin Endosc. 2023; 56:283–289. DOI:
10.5946/ce.2022.302. PMID:
37165534.
4. Alemanni LV, Fabbri S, Rondonotti E, et al. Recent developments in small bowel endoscopy: the "black box" is now open! Clin Endosc. 2022; 55:473–479. DOI:
10.5946/ce.2022.113. PMID:
35831981.
5. Lip GY, Benamouzig R, Martin AC, et al. Comparative safety and effectiveness of oral anticoagulants in patients with non-valvular atrial fibrillation and high risk of gastrointestinal bleeding: A nationwide French cohort study. PLoS One. 2024; 19:e0310322. DOI:
10.1371/journal.pone.0310322. PMID:
39546473.
6. Cosín-Sales J, Anguita Sánchez M, Suárez C, et al. Safety and effectiveness of oral anticoagulants in atrial fibrillation: real-world insights using natural language processing and machine learning. J Clin Med. 2024; 13:6226. DOI:
10.3390/jcm13206226. PMID:
39458177.
7. Bavishi C, Koulova A, Bangalore S, et al. Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies. Catheter Cardiovasc Interv. 2016; 88:E12–E22. DOI:
10.1002/ccd.26234. PMID:
26354765.
8. Abraham NS, Noseworthy PA, Inselman J, et al. Risk of gastrointestinal bleeding increases with combinations of antithrombotic agents and patient age. Clin Gastroenterol Hepatol. 2020; 18:337–346. DOI:
10.1016/j.cgh.2019.05.017. PMID:
31108228.
9. Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010; 138:1093–1100. DOI:
10.1378/chest.10-0134. PMID:
20299623.
10. Fang MC, Go AS, Chang Y, et al. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol. 2011; 58:395–401. DOI:
10.1016/j.jacc.2011.03.031. PMID:
21757117.
11. O'Brien EC, Simon DN, Thomas LE, et al. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation. Eur Heart J. 2015; 36:3258–3264. DOI:
10.1093/eurheartj/ehv476. PMID:
26424865.
12. Aggarwal R, Ruff CT, Virdone S, et al. Development and validation of the DOAC score: a novel bleeding risk prediction tool for patients with atrial fibrillation on direct-acting oral anticoagulants. Circulation. 2023; 148:936–946. DOI:
10.1161/circulationaha.123.064556. PMID:
37621213.